Researchers at University Hospital Zurich have reported a novel dual AAV strategy aimed to correct ABCA4 gene mutations for Stargardt disease (STGD1).
Researchers at the Laboratory for Retinal Gene Therapy, Department of Ophthalmology, University Hospital Zurich, Switzerland, have reported a novel treatment approach aimed to expand the… Read More »Researchers at University Hospital Zurich have reported a novel dual AAV strategy aimed to correct ABCA4 gene mutations for Stargardt disease (STGD1).